The invention relates to α-sulfin- and α-sulfonamino acid amides of the general formula I including the optical isomers thereof and mixtures of such isomers, wherein n is a number zero or one ; R, is C1-C12alkyl, C1-C12alkyl substituted with C1-C4alkoxy, C1-C4alkylthio, C1-C4alkylsulfonyl, C3-C8cycloalkyl, cyano, C,-C6alkoxycarbonyl, C3-C6alkenyloxycarbonyl or C3-C6alkynyloxycarbonyl ; Cs-Cgcydoatky) ; C2-C12alkenyl ; C2-C12alkynyl ; C1-C12 halogenalkyl ; or a group NR11R12 wherein Rn and Ri2 are each independently of the other C,-C6alkyl, or together are tetra-or penta-methylene ; R2 and R3 are each independently hydrogen ; C1-C8alkyl ; C,-C8alkyl substituted with hydroxy, mercapto, C,-C4alkoxy or C,-C4alkylthio ; C3-C8alkenyl ; C3-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycloalkyl-C1-C4alkyl ; or the two groups R2 and R3 together with the carbon atom to which they are bonded form a three-to eight-membered hydrocarbon ring ; R4, R5, R6 and R, are each independently hydrogen or C,-C4alkyl ; R8 is hydrogen or an organic radical ; Rg is an organic radical ; Rio ils either hydrogen, R, 3, R, 4, R, 6, R, 7 and R, g are each independently hydrogen or C1-C4alkyl, R, 5 is C4-C12alkyl ; C,-C, 2halogenalkyl ; C3-C8cycloalkyl ; optionally substituted aryl or optionally substituted heteroaryl, Rig is optionally substituted aryl or optionally substituted heteroaryl ; and Z is oxygen, sulfur-CR2oR2,-or-NR22-, wherein R2o, R2, and R22 independently of each other are hydrogen or C,-C4alkyl ; provided that when R8 is hydrogen, Rg is not C,-C6-alkoxy, C3-C6alkenyloxy or C3-C6-alkynyloxy in position 3 of the phenyl ring carrying these radicals.

In the above definition aryl includes aromatic hydrocarbon rings like phenyl, naphthyl, anthracenyl, phenanthrenyl, with phenyl being preferred.

Heteroaryl stands for aromatic ring systems comprising mono-, bi-or tricyclic systems wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member. Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotriazolyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quin- oxalinyl, quinazolinyl, cinnolinyl and naphthyridinyl.

The above aryl and heteroaryl groups may carry one or more identical or different substituents. Normally not more than three substituents are present at the same time.

Examples of substituents of aryl or heteroaryl groups are : alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenyl-alkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms ; alkoxy ; alkenyloxy ; alkynyloxy ; alkoxyalkyl ; halogenalkoxy, alkylthio ; halogenalkylthio ; alkylsulfonyl ; formyl ; alkanol ; hydroxy ; halogen ; cyano ; nitro ; amino ; alkylamino ; dialkylamino ; carboxy ; alkoxycarbonyl ; alkenyloxycarbonyl ; alkynyloxycarbonyl.

In the above definitions"halogen"or the prefix"halo"includes fluorine, chlorine, bromine and iodine.

The alkyl, alkenyl and alkynyl radicals may be straight-chain or branched. This applies also to the alkyl, alkenyl or alkynyl parts of other alkyl-, alkenyl-or alkynyl-containing groups.

The organic radical in R8 and Rg indicates that practically every substituent used in the art of organic chemistry may be placed in the indicated position at the phenylen bridge member.

Preferred are however the more frequently used radicals like C,-C8alkyl, C2-C8alkenyl, C2-Cealkynyl, C3-Cecycloalkyl, C3-C8Cycloalkyl-C,-C4alkyl, C,-Cealkylthio, C,-C8alkylsulfonyl,<BR> C,-C8alkoxy, C3-Csalkenyloxy, C3-Csalkynyloxy, C3-C8cycloalkoxy, C,-CBalkoxy-C,-C4alkyl,<BR> C,-C8alkoxycarbonyl, C3-Cealkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C,-C8alkanoyl, C1-C8dialkylamino, C1-C8alkylamino wherein in each of the above radicals the alkyl, alkenyl, alkynyl or cycloalkyl groups may be partially or fully halogenated ; carboxy, formyl, halogen, nitro, cyano, hydroxy or amino.

Depending upon the number of carbon atoms mentioned, alkyl on its own or as part of another substituent is to be understood as being, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the isomers thereof, for example isopropyl, isobutyl, ter-butyl or sec-butyl, isopentyl or tert-pentyl.

Cycloalkyl is, depending upon the number of carbon atoms mentioned, cyclopropyl, cyclo- butyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.

Depending upon the number of carbon atoms mentioned, alkenyl as a group or as a struc- tural element of other groups is to be understood as being, for example, ethenyl, allyl, 1-propenyl, buten-2-yl, buten-3-yl, penten-1-yl, penten-3-yl, hexen-1-yl, 4-methyl-3-pentenyl or 4-methyl-3-hexenyl.

Alkynyl as a group or as a structural element of other groups is, for example, ethynyl, propyn-1-yl, propyn-2-yl, butyn-1-yl, butyn-2-yl, 1-methyl-2-butynyl, hexyn-1-yl, 1-ethyl-2- butynyl or octyn-1-yl.

A halogenalkyl group may contain one or more (identical or different) halogen atoms, and for example may stand for CHC12, CH2F, CC13, CH2CI, CHF2, CF3, CH2CH2Br, C2CI5, CH2Br, CHCIBr, CF3CH2, etc..

Where R2 and R3 together with the carbon atom to which they are attached form a hydrocarbon ring the ring corresponds to cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane or cyclooctane The presence of at least one asymmetric carbon atom and/or at least one asymmetric oxidized sulfur atom in the compounds of formula I means that the compounds may occur in optically isomeric forms. As a result of the presence of a possible aliphatic C=C double bond, geometric isomerism may also occur. Formula I is intended to include all those possible isomeric forms and mixtures thereof.

Preferred subgroups of compounds of formula I are those wherein n is one ; or R, is C1-C12alkyl, C1-C12alkyl substituted with C1-C4alkoxy, C1-C4alkylthio, or Cl-C, alkylsulfonyl ; C3-C8cycloalkyl ; C2-C12alkenyl ; C2-C12alkynyl ; C1-C12halogenalkyl ; or a group NR11R12 wherein R11 and R12 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra-or penta-methylene ; or R, is C1-C12alkyl, C2-C12alkenyl ; C1-C12halogenalkyl; or a group NR11R12 wherein Ru and R12 are each independently of the other hydrogen or C1-C6alkyl ; or R, is C1-C4alkyl, C2-C4alkenyl ; C1-C4halogenalkyl ; or C1-C2dialkylamino ; or R, is C1-C4alkyl, vinyl ; C1-C4halogenalkyl ; or dimethylamino ; or R2 is hydrogen and R3 is C1-C8alkyl, C1-C8alkyl optionally substituted by hydroxy, C,-C4alkoxy, mercapto or C,-C4alkylthio ; Cs-Csaikeny) ; C3-C8alkynyl ; C3-C8cycloalkyl or C3-Ccycloalkyl-C1-C4alkyl ; or R2 is hydrogen and R3 is C1-C4aikyl ; C3-C4alkenyl or cyclopropyl ; or R2 is hydrogen and R3 is C3-C4alkyl ; allyl or cyclopropyl ; or R2 is hydrogen and R3 is isopropyl ; or R4 is hydrogen, methyl or ethyl ; or R4 is hydrogen or methyl ; or R4 is hydrogen ; or R5, R6 and R7 are each independently hydrogen or methyl ; or Rs, R6 and R7 are each hydrogen ; or R8 is hydrogen, C1-C8 C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C,-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, Cs-Caaikynytoxy, c3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-C8alkanoyl, C1-C8dialkylamino, C,-C8alkylamino wherein in each of the above radicals the alkyl, alkenyl, alkynyl or cycloalkyl groups may be partially or fully halogenated ; carboxy, formyl, halogen, nitro, cyano, hydroxy or amino ; or R8 is hydrogen, C1-C8alkyl, C1-C8halogenalkyl, C2-C8alkenyl, C2-C8alkynyl, C1-C8alkylthio, C1-Chalogenalkylthio, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alk- oxy-C,-C4alkyl, C,-Cealkoxycarbonyl, C,-Caalkanoyl, formyl, halogen, nitro, cyano or hydroxy ; or R8 is hydrogen, C1-C4alkyl, C1-Crhalogenalkyl, c1-C4alkoxy, C1-C4alkoxycarbonyl, C1-C4alkanoyl, formyl, halogen, cyano or hydroxy ; or R8 is hydrogen, C1-C4alkyl, halogen or cyano ; or Rg is C1-C8alkyl, C2-C8 alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cyclo- alkyl-C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8Cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C,-C8alkanoyl, C,-C8dialkylamino, C1-C8alkylamino wherein in each of the above radicals the alkyl, alkenyl, alkynyl or cycloalkyl groups may be partially or fully halogenated ; carboxy, formyl, halogen, nitro, cyano, hydroxy or amino, provided that when R8 is hydrogen, R9 is not C,-C6alkoxy, C3-C6al- kenyloxy or C3-C6alkynyloxy in position 3 of the phenyl ring carrying these radicals ; or Rg is C1-C4alkyl, C1-C4halogenalkyl, C1-C4alkoxy, C1-C4alkoxycarbonyl, C1-C4alkanoyl, formyl, halogen, cyano or hydroxy, provided that when R8 is hydrogen, R9 is not Ci-Cea ! koxy in position 3 of the phenyl ring carrying these radicals ; or Rg is C1-C4alkyl, halogen or cyano ; or R13, R14, R16, R17 and R19 are each independently hydrogen or methyl ; or Pis, R14, R16, R17 and R19 are each hydrogen ; or Pis is C4-C, 2alkyl ; C,-C12halogenalkyl ; C3-C8cycloalkyl ; optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur ; or Pis is C4-C12alkyl ; C1-C12 halogenalkyl; C3-C8cycloalkyl ; phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C,-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-CBcycloalkyl, C3-C8cycloalkyl-C,-C4alkyl, phenyl, phenyl-C,-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C,-C-alkoxy, C3-CBalken- yoxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8-alkanoyl, hydroxy, halogen, cyano, nitro, amino and C,-C8alkylamino, C,-C8dialkylamino, carboxy, C,-C8alkoxycarbonyl, C1 C8alkenyloxycarbonyl and C,-C8alkynyloxycarbonyl ; or R, 5 is C4-C, 2alkyl ; C,-C, 2halogenalkyl ; C3-C8cycloalkyl ; phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C,-C8alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C1-C8alkoxy, C,-C8halogenalkoxy, C1-C8alkylthio, c1-C8halogenalkylthio, halogen, cyano, nitro and C,-C8alkoxycarbonyl ; or Pis is C4-C8alkyl ; C,-C6halogenalkyl ; C3-C8cycloalkyl ; phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of c1-C8alkyl, C1-C8halogenalkyl, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C,-C8halogenalkylthio, halogen, cyano, nitro and C,-C8alkoxycarbonyl ; or Pis is optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur ; or Rie is phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, phenyl, phenyl-C1-C4-alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C,-C8alkoxy, C3-Cealkenyloxy, C3-Cealkynyloxy, C,-C8alkoxy-C,-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, Cs-Csaikanoyi, hydroxy, halogen, cyano, nitro, amino, C,-C8alkylamino, C,-Cedialkylamino, carboxy, C,-C8alkoxycarbonyl, C, Cealkenyloxycarbonyl and Cl-C8alkynyloxycarbonyl ; or Rig is phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C,-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C,-Cealkoxycarbonyl ; or Ris is phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl, C,-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C,-C8-alkoxycarbonyl ; or Z is oxygen, sulfur or-CH2- ; or Z is oxygen.

Further preferred subgroups of the compounds of formula I are those wherein 1) R, is C,-C12alkyl, C,-C, 2alkyi substituted with C,-C4alkoxy, C,-C4alkylthio, or C1-C4alkylsulfonyl ; C3-C8cycloalkyl ; C2-C12alkenyl; c2-C12alkynyl ; Cl-Cl2halogenalkyl ; or a group NR11R12 wherein Rn and Riz are each independently of the other hydrogen or C,-C6alkyl, or together are tetra-or penta-methylene ; R2 is hydrogen and R3 is C,-C8alkyl ; C1-C8alkyl substituted with hydroxy, mercapto, C1-C4alkoxy or C,-C4alkylthio ; C3-C8alkenyl ; C3-C8alkynyl ; C3-C8cycloalkyl ; C3-C8cycloal- kyl-C1-C4alkyl ; R8 is hydrogen, C,-C8-alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8Cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, C1-C8alkylthio, C1-C8alkylsulfonyl, C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, Ci-Cgatkoxycarbonyt, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C,-Cgalkanoyl, C,-C8dialkylamino, C1-C8alkylamino wherein in each of the above radicals the alkyl, alkenyl, alkynyl or cycloalkyl groups may be partially or fully halogenated ; carboxy, formyl, halogen, nitro, cyano, hydroxy or amino ; Rg is C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cyclo- alkyl-C,-C4alkyl, C,-C8alkylthio, C,-C8alkylsulfonyl, C,-C8alkoxy, C3-C8aikenyloxy, C3-C8alkynyloxy, C3-C8cycloalkoxy, C1-C8alkoxy-C1-C4alkyl, C1-C8alkoxycarbonyl, C3-C8alkenyloxycarbonyl, C3-C8alkynyloxycarbonyl, C1-C8alknoyl, C1-C8dialkylamino, C1-C8alkylamino wherein in each of the above radicals the alkyl, alkenyl, alkynyl or cycloalkyl groups may be partially or fully halogenated ; carboxy, formyl, halogen, nitro, cyano, hydroxy or amino, provided that when Ra is hydrogen, Rg is not C,-C6alkoxy, C3-C6alkenyloxy or C3-C6alkynyloxy in position 3 of the phenyl ring carrying these radicals R, 5 is C4-C12alkyl ; C1-C12halogenalkyl ; C3-C8cycloalkyl ; optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur ; and Ris is optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur ; or 2) n is one ; R, is C,-C, 2alkyl, C2-C, 2alkenyl ; C1-C12halogenalkyl; or a group NRRis wherein R" and R, 2 are each independently of the other hydrogen or d-Ceaikyi ; R2 is hydrogen and R3 is C1-C4alkyl ; C3-C4alkenyl or cyclopropyl ; R4 is hydrogen, methyl or ethyl ; R5, R6 and R7 are each independently hydrogen or methyl ; or R8 is hydrogen, C1-C8alkyl, C,-CBhalogenalkyl, C2-C8alkenyl, C2-C8alkynyl, C1-Caalkylthio, C1-C8halogenalkylthio, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alk- xy-C1-C4alkyl, C1-C8alkoxycarbonyl, C1-C*alkanoyl, formyl, halogen, nitro, cyano or hydroxy ; R9 is C1-C4alkyl, C1-C4halogenalkyl, C1-C4alkoxy, C1-C4alkoxycarbonyl, C1-C4alkanoyl, formyl, halogen, cyano or hydroxy, provided that when Ra is hydrogen, Rg is not Ci-Cea ! koxy in position 3 of the phenyl ring carrying these radicals ; R13, R14, R16, R17 and Rie are each independently hydrogen or methyl ; or R, 5 is C4-C12alkyl ; C-C, 2halogenalkyl ; C3-C8cycloalkyl ; phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8aikenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, phenyl, phenyl-C1-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C,-C-alkoxy, C3-C8alken- yloxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8-alkanoyl, hydroxy, halogen, cyano, nitro, amino, C,-C8alkylamino, C,-C8dialkylamino, carboxy, C1-C8alkoxycarbonyl, Cl-C8alkenyloxycarbonyl and Cl-C8alkynyloxycarbonyl ; Ris is phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-Cralkyl, phenyl, phenyl-C1-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C,-C8alkoxy, C3-Csalkenyloxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C,-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino, C,-C8alkylamino, C,-C8dialkylamino, carboxy, C,-Cealkoxycarbonyl, C,. C8alkenyloxycarbonyl and C1-C8alkynyloxycarbonyl ; and Z is oxygen, sulfur or-CH2- ; or 3) n is one ; R, is C,-C4alkyl, C2-C4alkenyl ; C1-C4halogenalkyl ; or C1-C2dialkylamino ; R2 is hydrogen and R3 is C3-C4alkyl ; allyl or cyclopropyl ; R4 is hydrogen or methyl ; R5, R6, R7, R13, R14, R16, R17 and R19 are each hydrogen ; R8 is hydrogen, C1-C4alky, C1-C4halogenalkyl, C1-C4alkoxy, C1-C4alkoxycarbonyl, C1-C4alkanoyl, formyl, halogen, cyano or hydroxy ; Rg is C1-C4alkyl, halogen or cyano ; Pis is C4-C12alkyl ; C1-C12halogenalkyl; C3-C8cycloalkyl ; phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C1-C8alkoxy, C1-C8halogenalkoxy, C,-C8alkylthio, C,-CBhalogenalkylthio, halogen, cyano, nitro and C,-C8alkoxycarbonyl ; Pie 8 is phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C,-C8-alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms ; C1-C8alkoxy, C,-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C,-C8alkoxycarbonyl ; and Z is oxygen, sulfur or-CH2- ; or 4) n is one ; R, is C1-C4alkyl, vinyl ; C,-C4halogenalkyl ; or dimethylamino ; R2 is hydrogen and R3 is isopropyl ; R4, R5, R7, R, R12, R14, R15 and R17 are each hydrogen ; RB is hydrogen ; Rg is C1-C4alkyl, halogen or cyano ; R, 5 is C4-C8alkyl ; C1-C6halogenalkyl ; C3-C8cycloalkyl ; phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl,C1-C8alkoxy, C1-C8halogenalkoxy, C,-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C,-C8alkoxycarbonyl ; R, 8 is phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-C8-alkoxycarbonyl ; and Z is oxygen.

Preferred individual compounds are : N-(2-{3-bromo-4-[3-(4-chloro-phenyl)-prop-2-ynyloxy]-5-metho xy-phenyl}-ethyl)-2- ethanesulfonylamino-3-methyl-butyramide, N-(2-{3-bromo-4-[3-(4-bromo-phenyl)-prop-2-ynyloxy]-5-methox y-phenyl}-ethyl)-2- ethanesulfonylamino-3-methyl-butyramide,<BR> N- (2- {3-bromo-4- [3- (4-fluoro-phenyl)-prop-2-ynyloxy]-5-methoxy-phenyl ?-ethyl)-2- ethanesulfonylamino-3-methyl-butyramide, N- {2- [3-bromo-4- (3-cyclopropyl-prop-2-ynyloxy)-5-methoxy-phenyl]-ethyl}-2- ethanesulfonylamino-3-methyl-butyramide, N- (2- {3-bromo-4- [3- (4-chloro-phenyl)-prop-2-ynyloxy]-5-methoxy-phenyl}-ethyl)-2 - methanesulfonylamino-3-methyl-butyramide, N- (2- {3-bromo-4- [3- (4-bromo-phenyl)-prop-2-ynyloxy]-5-methoxy-phenyl}-ethyl)-2- <BR> methanesulfonylamino-3-methyl-butyramide,<BR> N- (2- {3-bromo-4- [3- (4-fluoro-phenyl)-prop-2-ynyloxy]-5-methoxy-phenyl}-ethyl)-2 - methanesulfonylamino-3-methyl-butyramide, N- {2- [3-bromo-4- (3-cyclopropyl-prop-2-ynyloxy)-5-methoxy-phenyl]-ethyl}-2-&l t;BR> methanesu If onylamino-3-methyl-butyramide,<BR> N- (2- {4- [3- (4-chloro-phenyl)-prop-2-ynyloxy]-3, 5-dimethoxy-phenyl}-ethyl)-2-<BR> ethanesulfonylamino-3-methyl-butyramide,<BR> N- (2- (4- [3- (4-bromo-phenyl)-prop-2-ynyloxy]-3, 5-dimethoxy-phenyl)-ethyl)-2-<BR> ethanesulfonylamino-3-methyl-butyramide,<BR> N- (2- {4- [3- (4-fluoro-phenyl)-prop-2-ynyloxy]-3, 5-dimethoxy-phenyl}-ethyl)- 2- ethanesulfonylamino-3-methyl-butyramide, N- (2- {4- [3- (4-chloro-phenyl)-prop-2-ynyloxy]-3, 5-dimethoxy-phenyl}-ethyl)-2- methanesulfonylamino-3-methyl-butyramide, N- (2- {4- [3- (4-bromo-phenyl)-prop-2-ynyloxy]-3, 5-dimethoxy-phenyl}-ethyl)-2- methanesulfonylamino-3-methyl-butyramide, N- (2- {4- [3- (4-fluoro-phenyl)-prop-2-ynyloxy]-3, 5-dimethoxy-phenyl}-ethyl)-2- methanesulfonylamino-3-methyl-butyramide, N- {2- [4- (3-cyclopropyl-prop-2-ynyloxy)-3, 5-dimethoxy-phenyl]-ethyl}-2-ethanesulfonylamino- 3-methyl-butyramide, and N- {2- [4- (3-cyclopropyl-prop-2-ynyloxy)-3, 5-dimethoxy-phenyl]-ethyl}-2- methanesulfonylamino-3-methyl-butyramide.

Certain a-sulfin-and a-sulfonamino acid derivatives having a different kind of structure have already been proposed for controlling plant-destructive fungi (for example in WO 95/030651, WO 97/14677, WO 98/38160 and WO 98/38161). The action of those preparations is not, however, satisfactory in all aspects of agricultural needs. Surprisingly, with the compound structure of formula 1, new kinds of microbicides having a high level of activity have been found.

The a-sulfin-and a-sulfonamino acid amides of formula I may be obtained according to one of the following processes : a) R2 R,-S-X + H2N COOH i V R3 IV Step A r (0)"R R R R8 I H I OH + HzN R, o O R3 R5 R7 R9 9 111 StepB Step B R2 O R4 R6 R 0 R R "9) Ru I An amino acid of formula 11 or a carboxy-activated derivative of an amino acid of formula 11 wherein Ri, n, R2 and R3 are as defined for formula I is reacted with an amine of formula III wherein R4, R5, R6, R7, R8, Rg and Rlo are as defined above optionally in the presence of a base and optionally in the presence of a diluting agent (step B).

Carboxy-activated derivatives of the amino acid of formula 11 encompasses all compounds having an activated carboxyl group like an acid halide, such as an acid chloride, like symmetrical or mixed anhydrides, such as mixed anhydrides with O-alkylcarbonates, like activated esters, such as p-nitrophenylesters or N-hydroxysuccinimidesters, as well as in situ produced activated forms of the amino acid of formula 11 by condensating agents, such as dicyclohexylcarbodiimide, carbonyldiimidazol, benzotriazol-1-yloxy-tris (dimethylamino)- phosphonium hexafluorophosphate, O-benzotriazol-1-yl N, N, N', N'-bis (pentamethylene)- uronium hexafluorophosphate, O-benzotriazol-1-yl N, N, N', N'-bis (tetramethylene) uronium hexafluorophosphate, O-benzotriazol-1-yl N, N, N', N'-tetramethyluronium hexafluoro- phosphate or benzotriazol-1-yloxy-tripyrrolidinophosphonium hexafluorophosphate. The mixed anhydrides of the amino acids of the formula 11 may be prepared by reaction of an amino acid of formula 11 with chloroformic acid esters like chloroformic acid alkylesters, such as ethyl chloroformate or isobutyl chloroformate, optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine.

The present reaction is preferably performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e. g. dichloromethane or toluene ; ketones, e. g. acetone ; esters, e. g. ethyl acetate ; amides, e. g. N, N-dimethyl- formamide ; nitriles e. g. acetonitrile ; or ethers e. g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofurane or water. It is also possible to use mixtures of these solvents.

The reaction is preformed optionally in the presence of an organic or inorganic base like a tertiary amine, e. g. triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from-80°C to +150°C, preferentially at temperatures ranging from-40°C to +40°C.

The compounds of formula 11 may be prepared by reaction of an amino acid of formula IV where R2 and R3 are as defined for formula I with a sulfonyl halide or a sulfinyl halide of formula V where R, and n have the same meanings as defined above and where X is halide, preferentially chlorine or bromine (step A).

The reaction may be performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons, e. g. dichloromethane or toluene ; ketones, e. g. acetone ; esters, e. g. ethyl acetate ; ethers, e. g. diethylether, tert-butyl- methylether, dioxane or tetrahydrofurane or water. It is also possible to use mixtures of these solvents. The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from-80°C to +150°C, preferentially at temperatures ranging from-40°C to +40°C. b) Rz O RQ Rs T Ri S-X + H2N I N I I O-Rio U R3 R5 R'R v I Step C i 0 R4 R6 R8 o R3 R5 R7 R9 T 11 H I H I I rus Rs R7 R9 I R9 I The compounds of formula I may also be prepared by reaction of an amino acid derivative of formula VI wherein R2, R3, R4, R5, R6, R7, R8, R 9 and Rio are as defined for formula I with a sulfonyl halide or a sulfinyl halide of formula V wherein R, and n are as defined for formula I and X is halide, preferentially chlorine or bromine (step C). The reaction is performed in the same manner as described for step A. c) Rs R2 O R4 R6 +4 R ( R n R R ? s Vll VIT Step D R8 R R4 R6 T V)) Steps s The compounds of formula I may also be prepared by reaction of a phenol of formula VII wherein Ri, n, R2, R3, R4, R5, R6, R7, R8 and Rg are as defined for formula I with a compound of formula Viol wherein Rio is as defined for formula I and Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate (step D).

The reaction may be performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e. g. dichloromethane or toluene ; ketones e. g. acetone or 2-butanone ; esters, e. g. ethyl acetate ; ethers, e. g. diethylether, tert- butyl-methylether, dioxane or tetrahydrofurane, amides, e. g. dimethylformamide, nitriles, e. g. acetonitrile, alcohols, e. g. methanol, ethanol, isopropanol, n-butanol or tert-butanol, sulfoxides e. g. dimethylsulfoxide or water. It is also possible to use mixtures of these solvents. The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N, N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide, a metal carbonate or a metal alkoxide, preferentially an alkali hydroxide, an alkali carbonate or an alkali alkoxide, such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, sodium tert-butoxide or potassium tert-butoxide at temperatures ranging from-80°C to +200°C, preferentially at temperatures ranging from 0°C to +120°C. d) O R T (0)"R2 0 R4 R6 8 R13 StepE t' 'R9 VII Ra Vllla Stem E (0)"R2 Ra Rs Rg Rts I I T o R3 R5 R7 Rg Vll R14 Vlila 0 H Rs Rs R R R, a IX s Step F O R R2 n Rs 8 Rs T S H I H R, s la o H3 R5 R7 Rg R14 H 9 (1l) n XH X R 0t The compounds of formula la may also be prepared via formula IX wherein Ri, n, R2, R3, R4, R5, R6, R7, R8, Ri3-Ri4 and R, 5 are defined for formula I by reacting of a phenol of formula VII wherein Ri, n, R2, R3, R4, R5, R6, R7, R8 and Rg are as defined for formula I with a compound of formula Vllla wherein Ris, Ri4 and R, 5 are as defined for formula I and Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylat, mesylate or triflate (step E).

The reaction is performed in the same manner as described for step D.

The compounds of formula la R13, R14 and R, 5 is as defined for formula I may be prepared by reaction of compounds of formula IX with hydrogen.

The reaction is performed in a solvent like ethers, e. g. diethylether, dioxane or tetrahydrofuran, or like alcohols, e. g. methanol or ethanol, or water in the presence of transition metals or transition metal salts, e. g. nickel, cobalt, palladium, platinum or rhodium, optionally in the presence of bases, e. g. ammonia, or in the presence of salts, e. g. barium sulfate, at temperatures ranging from-20°C to +160°C and at pressures ranging from 1 to 200 bar. aa) The intermediate amines of formula III may be obtained by one of the following processes : Procedure 1 : NOZ CHO CHU step 1 R8 R9 step 2--st-ep-3-w- RI R9-0-R R9--------III Re Rs R R III Oh !' OH O XIX R, o XX I XXI Rio Procedure 2 : Ra RQ O [34 NOH Rs R Rs R Rs R step 1 step 4 step 3 R9 R8 R9 RB R9----I R 8 9 8 9 OH XXII Oj Õ Rro | XXIV Rio Rio Procedure 3 : CN OH CN R6 ruz R 6 R7 R6 R7 step 5 step 1/step 3 // Re R9 III Ra \ Rs RB \ Rs O OH XXV OH XXVI I XXVII Rio Procedure 4 : COOR COOR COOH R4 Rs R4 Rs R4 Rs a step 7 R R Rs Rg Rs 'step 1 step 6 step 7 ! 00 R R R Re \ s a \ s a i O O OH XXVIII I XXIX I XXX Rio Rio Step 1 is the alkylation of a phenol with a compound of formula VIIl. The reaction is performed in the same manner as described for procedure c).

Step 2 is the reaction of an aromatic aldehyde with nitromethane. This reaction is performed in a solvent like an organic carboxylic acids, e. g. acetic acid optionally in the presence of the ammonium salt of this carboxylic acid, e. g. ammonium acetate at temperatures ranging from 0°C to +200 °C.

Step 3 is the reduction of an unsaturated nitrogen-compound. This reaction is performed in a solvent like an ether, e. g. diethylether, dioxane or tetrahydrofuran, or an alcohol, e. g. methanol, ethanol or isopropanol, with borohydride, with a boron-complex, e. g. the complex of borohydride with tetrahyrofuran, with an alkaliborohydride, with an alkalialuminiumhydride, e. g. lithiumaluminiumhydride, with aluminiumhydride, with an aluminiumalkoxyhydride or with hydrogen optionally in the presence of a transition metal, a transition metal salt or a transition metal complex, e. g. nickel, cobalt, palladium, platinum or rhodium at temperatures ranging from-50°C to +200°C.

Step 4 is the reaction of an aldehyde or a ketone of formula with hydroxylamine or with a salt of hydroxylamine. This reaction is performed in a solvent like an alcohol, e. g. methanol, ethanol or isopropanol, like an ether, e. g. diethylether, dioxane or tetrahydrofuran, like an amide, e. g. dimethylformamide, or in water or in a mixture of these solvents optionally in the presence of an organic or inorganic base like a tertiary amine, e. g. triethylamine, like a heterocyclic compound containing nitrogen, e. g. pyridine, or like an alkalicarbonate, e. g. sodium carbonate or potassium carbonate, at temperatures ranging from-20°C to +150°C.

Step 5 is the exchange of hydroxy by cyanide. This reaction is performed in an organic solvent like an amide, e. g. dimethylformamide using a metal cyanide like an alkali cyanide, e. g. sodium cyanide or potassium cyanide, at temperatures ranging from 0°C to +200°C.

Step 6 is the hydrolysis of an alkyl ester. This reaction is performed in a solvent like an alcohol, e. g. methanol, ethanol or isopropanol, like an ether, e. g. diethylether, dioxane or tetrahydrofuran, like a halogenated hydrocarbon, e. g. dichloromethane, or water or in a mixture of these solvents optionally in the presence of an alkali hydroxide, e. g. lithium hydroxide, sodium hydroxide or potassium hydroxide, or optionally in the presence of an acid, e. g. hydrogen chloride, sulfuric acid or trifluoroacetic acid at temperatures ranging from-20°C to +160°C.

Step 7 is the reaction of a carboxylic acid or the activated form of this carboxylic acid with hydrogen azide or an azide-salt. An activated form of a carboxylic acid can be the acid halogenide, e. g. acid chloride, a symmetric or a mixed anhydride. Azide-salts can be alkali azides, e. g. sodium azide. The reaction is performed in a solvent like a hydrocarbon, e. g. toluene or xylene, like a halogenated hydrocarbon, e. g. chloroform, like an ether, e. g. dioxane, like a ketone, e. g. acetone or 2-butanone, like an alcohol, e. g. methanol, ethanol or tert-butanol, or water or in a mixture of these solvents optionally in the presence of an acid like an inorganic acid, e. g. sulfuric acid or hydrogen chloride at temperatures ranging from-40°C to +200°C.

In a preferred form the compounds of formula XXVI are prepared starting from compounds of the formula XXV by applying step 5 and step 1 in the same pot. bb) Amines of formula VI can be obtained by the following process : R$ O R2 R4 R6 R-0 11 HN+COOH + H 2N I _ OH . n Rs XXXIV XXX I I I step8 R O Ra R Ra R-O-'HN-j--HN s \ OH R 3 R5R7 R9 xxxv s XXXV + VIII step 9 Ra + R20 R4 R6 RB R-0 11 HN 1 11 O-Rio . __O_ "9 XXVI step 10 Vl wherein R is lower alkyl or optionally substituted benzyl.

Step 8 is the amidation of an carbamate-protected amino acid of formula XXXIII with an amine of formula XXXIV. The reaction is performed in the same manner as described for step A.

Step 9 is the alkylation of a phenol of formula XXXV with an compound of formula VIII. The reaction is performed in the same manner as described for step D.

Step 10 is the hydrolysis of a carbamate of formula XXXVI. The reaction is performed in a solvent like hydrocarbons, e. g. toluene, like halogenated hydrocarbons, e. g. dichloromethane, like ketones, e. g. acetone, like esters, e. g. ethyl acetate, like ethers, e. g. dioxane or tetrahydrofuran, or like water or in mixtures of these solvents optionally in the presence of an organic acid like carboxylic acid, e. g. trifluoroacetic acid, or like a sulfonic acid, e. g. methanesulfonic acid or toluenesulfonic acid, or in the presence of an inorganic acid, e. g. hydrogen chloride or sulfuric acid, at temperatures ranging from-40°C to +160°C.

The compounds of formula I are oils or solids at room temperature and are distinguished by valuable microbiocidal properties. They can be used in the agricultural sector or related fields preventively and curatively in the control of plant-destructive microorganisms. The compounds of formula I according to the invention are distinguished at low rates of concen- tration not only by outstanding microbiocidal, especially fungicidal, activity but also by being especially well tolerated by plants.

Surprisingly, it has now been found that the compounds of formula I have for practical purposes a very advantageous biocidal spectrum in the control of phytopathogenic micro- organisms, especially fungi. They possess very advantageous curative and preventive properties and are used in the protection of numerous crop plants. With the compounds of formula I it is possible to inhibit or destroy phytopathogenic microorganisms that occur on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later also remain protected, for example, against phytopathogenic fungi.

The novel compounds of formula I prove to be effective against specific genera of the fungus class Fungi imperfecti (e. g. Cercospora), Basidiomycetes (e. g. Puccinia) and Ascomycetes (e. g. Erysiphe and Venturia) and especially against Oomycetes (e. g.

Plasmopara, Peronospora, Pythium and Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phytopathogenic fungi. The compounds of formula I can also be used as dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phytopathogenic fungi that occur in the soil.

The invention relates also to compositions comprising compounds of formula I as active ingredient, especially plant-protecting compositions, and to the use thereof in the agri- cultural sector or related fields.

In addition, the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances described herein. Also included is a method of treating plants which is distin- guished by the application of the novel compounds of formula I or of the novel compositions.

Target crops to be protected within the scope of this invention comprise, for example, the following species of plants : cereals (wheat, barley, rye, oats, rice, maize, sorghum and related species) ; beet (sugar beet and fodder beet) ; pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and black- berries) ; leguminous plants (beans, lentils, peas, soybeans) ; oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts) ; cucurbi- taceae (marrows, cucumbers, melons) ; fibre plants (cotton, flax, hemp, jute) ; citrus fruit (oranges, lemons, grapefruit, mandarins) ; vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika) ; lauraceae (avocado, cinnamon, camphor) and plants such as tobacco, nuts, coffee, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, and also ornamentals.

The compounds of formula I are normally used in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with other active ingredients. Those other active ingredients may be fertilisers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides or insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application- promoting adjuvants customarily employed in formulation technology.

The compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.

Mixing components which are particularly preferred are azoles such as azoles, such as azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole ; pyrimidinyl carbinols, such as ancymidol, fenarimol, nuarimol ; 2-amino-pyrimidines, such as bupirimate, dimethirimol, ethirimol ; morpholines, such as dodemorph, fenpropidine, fenpropimorph, spiroxamine, tridemorph ; anilinopyrimidines, such as cyprodinil, mepanipyrim, pyrimethanil ; pyrroles, such as fenpiclonil, fludioxonil ; phenylamides, such as benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl ; benzimidazoles, such as benomyl, carbendazim, debacarb, fuberidazole, thiabendazole ; dicarboximides, such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone, vinclozolin ; carboxamides, such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, thifluzamide ; guanidines, such as guazatine, dodine, iminoctadine ; strobilurines, such as azoxystrobin, kresoxim-methyl, metominostrobin, SSF-129, CGA 279202 (trifloxystrobin), picoxystrobin ; dithiocarbamates, such as ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram ; N-halogenmethylthiophthalimides, such as captafol, captan, dichlofluanid, fluoromide, folpet, tolyfluanid ; Cu compounds, such as Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper, oxine-copper ; nitrophenol derivatives, such as dinocap, nitrothal-isopropyl ; organo-P derivatives, such as edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazophos, tolclofos-methyl ; various, such as AC 382042, acibenzolar-S-methyl, anilazine, blasticidin-S, quinomethionat, chloroneb, chlorothalonil, cymoxanil, dichlone, diclomezine, dicloran, diethofencarb, dimethomorph, dithianon, etridiazole, famoxadone, fenamidone, fenhexamid, fentin, ferimzone, fluazinam, flusulfamide, fosetyl-aluminium, hymexazol, IKF- 916, iprovalicarb, kasugamycin, methasulfocarb, MON65500, pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, RH-7281, RPA 407213, BAS 50001 F, sulfur, SYP-Z071, triazoxide, tricyclazole, triforine, validamycin.

Suitable carriers and surfactants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as e. g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilisers. Such carriers and additives are described, for example, in WO 95/30651.

A preferred method of applying a compound of formula 1, or an agrochemical composition comprising at least one of those compounds, is application to the foliage (foliar application), the frequency and the rate of application depending upon the risk of infestation by the pathogen in question. The compounds of formula I may also be applied to seed grains (coating) either by impregnating the grains with a liquid formulation of the active ingredient or by coating them with a solid formulation.

The compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e. g. into emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and by encapsulation in e. g. polymer substances. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended object- ives and the prevailing circumstances.

Advantageous rates of application are normally from 1 g to 2 kg of active ingredient (a. i.) per hectare (ha), preferably from 10 g to 1 kg a. i./ha, especially from 25 g to 750 g a. i./ha.

When used as seed dressings, rates of from 0. 001 g to 1. 0 g of active ingredient per kg of seed are advantageously used.

The formulations, i. e. the compositions, preparations or mixtures comprising the com- pound (s) (active ingredient (s)) of formula I and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e. g. by homogeneously mixing and/or grinding the active ingredient with extenders, e. g. solvents, solid carriers and, where appropriate, surface-active compounds (surfactants).

Further surfactants customarily used in formulation technology will be known to the person skilled in the art or can be found in the relevant technical literature.

The agrochemical compositions usually comprise 0. 01 to 99 % by weight, preferably 0. 1 to 95 % by weight, of a compound of formula 1, 99. 99 to 1 % by weight, preferably 99. 9 to 5 % by weight, of a solid or liquid adjuvant, and 0 to 25 % by weight, preferably 0. 1 to 25 % by weight, of a surfactant.

Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.

The compositions may also comprise further ingredients, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as fertilisers or other active ingredients for obtaining special effects.

The Examples which follow illustrate the invention described above, without limiting the scope thereof in any way. Temperatures are given in degrees Celsius.

Preparation Examples for compounds of formula I : xample A1. 1 : (S)-N- (2-3-Bromo-4- [3- (4-chloro-phenyl)-prop-2-ynyloxy]-5-methoxy-pheny ethVl)-2-ethanesulfonvlamino-3-methvl-butyramide A mixture of (S)-N- [2- (3-bromo-4-hydroxy-5-methoxy-phenyl)-ethyl]-2-ethanesulfonyl amino- 3-methyl-butyramide (1. 5 g), toluene-4-sulfonic acid 3- (4-chloro-phenyl)-prop-2-ynyl ester (1. 7 g) and sodium methoxide (6. 5 ml, 1 M solution in methanol) in methanol (40 ml) is heated to reflux for 2 hours. After cooling water (500 ml) is added. The mixture is extracted with ethyl acetate (2 x 500 ml). The organic layers are washed with brine (2 x 100 ml), combined, dried (MgSO4) and the solvent is evaporated. (S)-N-(2-{3-Brome-4-[3-(4-chloro- phenyl)-prop-2-ynyloxy]-5-methoxy-phenyl}-ethyl)-2-ethanesul fonylamino-3-methyl- butyramide is obtained and is purified by flash-column chromatography on silica gel (ethyl acetate/hexane) and recrystallization (ethyl acetate/hexane), m. p. 109-111°C.

Analogously to example A1. 1 the compounds listed in table A1 are obtained.

*) Configuration on the a-C-atom in the amino acid moiety ; Ph means phenyl Table A1 : No R1 *) R3 R4 R8 R9 R10 m.p. (°C) A1. 1 CH3-CH2- (S) (CH3) 2CH- H 3-OCH3 5- (4-CI-Ph)-C---C-CH2-109-111 Br A1. 2 CH3-CH2- (S) (CH3) 2CH- H 3-OCH3 5- (3, 4-di-Cl-Ph)-CH2- 148-150 Br A1. 3 CH3- (S) (CH3) 2CH- H 2-OCH3 H (4-CI-Ph)-C_C-CH2-129-130 A1. 4 CH3- (S) (CH3) 2CH- H 2-OCH3 H (4-Br-Ph)-C#C-CH2- 133-135 A1. 5 CH3- (S) (CH3) 2CH-H 3-CI H (4-CI-Ph)-C-C-CH2-156-157 A1. 6 CH3- (S) (CH3) 2CH- H 3-CI H (4-Br-Ph)-C=C-CH2-155-156 A1. 7CH3-CH2- (S) (CH3)2CH- H 3-Br H (4-Cl-Ph)-C#C-CH2- 147-149 A1. 8CH3-CH2- (S) (CH3) 2CH-H 3-Br H (4-CH3-Ph)-C-C-CH2-124-126 Example A2. 1. : (S)-N- [2-(3-Bromo-4-hydroxy-5-methoxy-phenyl)-ethyl]-2- ethanesulfonylamino-3-methyl-butyramide (S)-N- [2- (4-Benzyloxy-3-bromo-5-methoxy-phenyl)-ethyl]-2-ethanesulfon ylamino-3-methyl- butyramide (11. 7 g) and palladium (3. 6 g, 5% on charcoal) in tetrahydrofuran (200 ml) are shaken under a hydrogen atmosphere at +20 to +22°C and at normal pressure for 30 hours. The reaction mixture is filtered and evaporated. (S)-N- [2- (3-Bromo-4-hydroxy-5- methoxy-phenyl)-ethyl]-2-ethanesulfonylamino-3-methyl-butyra mide is obtained, and is purified by flash-column chromatography on silica gel (ethyl acetate/hexane) and recrystallization (ethyl acetate/hexane), m. p. 145-147°C.

Analogously to example A2. 1 the compounds listed in table A2 are obtained.

*) Configuration on the a-C-atom in the amino acid moiety Table A2 : No R1) R3 R4 R8 Rg m. p. (°C) A2. 1 CH3-CH2- (S) (CH3) 2CH- H 3-OCH3 Br 145-147 A2. 2 CH3- (S) (CH3) 2CH- H 2-OCH3 H 123-125 A2. 3 CH3- (S) (CH3) 2CH-H 3-CI H 146-151 Example A3. 1 : (S)-N-f2- (4-Benzyloxy-3-bromo-5-methoxy-phenyl)-ethyJ-2- ethanesulfonylamino-3-methyl-butyramide To (S)-2-Ethanesulfonylamino-3-methyl-butyric acid (15. 6 g), 2- (4-benzyloxy-3-bromo-5- methoxy-phenyl)-ethylamine (25 g) and N, N-diisopropylethylamine (27 ml) in N, N-Dimethyl- formamide (300 ml) is added benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphate (36. 2 g) in one portion. The reaction mixture is stirred at room temperature for 4 hours. Water (1 I) is then added. The mixture is extracted with ethyl acetate (2 x 500 ml). The organic layers are washed with brine (2 x 100 ml), combined, dried (MgS04) and the solvent is evaporated. (S)-N- [2- (4-Benzyloxy-3-bromo-5-methoxy- phenyl)-ethyl]-2-ethanesulfonylamino-3-methyl-butyramide is obtained, and is purified by flash-column chromatography on silica gel (ethyl acetate/hexane) and recrystallization (ethyl acetate/hexane), m. p. 128-130°C.

Analogously to example A3. 1 the compounds listed in table A3 are obtained.

*) Configuration on the a-C-atom in the amino acid moiety ; Ph means phenyl Table A3 : No R1 *) R3 R4 R8 R9 m.p. (°C) 3. 1. CH3-CH2- (S) (CH3) 2CH- H 3-OCH3 5-Br 141-152 3. 2. CH3-CH2- (S) (CH3) 2CH- H Ph-CH2-H 165-167 3. 3. (CH3) 2N- (S) (CH3) 2CH- H Ph-CH2-H 108-109 3. 4. CH3- (S) (CH3) 2CH- H 2-OCH3 H 168-169 3. 5. CH3- (S) (CH3)2CH- H 3-Cl H 178-179 Analogously to the above Examples the following compounds of Tables 1 to 16 may be prepared. In the tables Ph means phenyl.

Table 1 : Compounds represented by the Formula 1. 1 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A.

Table 2 : Compounds represented by the Formula 1. 2 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A.

Table 3 : Compounds represented by the Formula 1. 3 wherein the combination of the groups Pi, Ra and Rio corresponds to each row in table A.

Table 4 : Compounds represented by the Formula 1. 4 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A.

Table 5 : Compounds represented by the Formula 1. 5 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A. Table 6 : Compounds represented by the Formula 1. 6 wherein the combination of the groups Ri, Rs and Rio corresponds to each row in table A.

Table 7 : Compounds represented by the Formula 1. 7 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A.

Table 8 : Compounds represented by the Formula 1. 8 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A.

Table 9 : Compounds represented by the Formula 1. 9 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A.

Table 10 : Compounds represented by the Formula 1. 10 wherein the combination of the groups Ri, R3 and Rio corresponds to each row in table A. Table 11 : Compounds represented by the Formula 1. 11 wherein the combination of the groups Pi, Ra and Rio corresponds to each row in table A.

Table A No. R, R3 Rio 001 CH3-CH3-CH2-CH3-(CH2) 3-C-C-CH2- 002 CH3-CH2-CH3-CH2-CH3- (CH2) 3-C-C-CH2- 003 (CH3) 2N-CH3-CH2-CH3-(CH2) 3-C-C-CH2- 004 CH3-CH2-CH2-CH3-CH2-CH3- (CH2) 3-C-=C-CH2- 005 (CH3) 2CH- CH3-CH2-CH3- (CH2) 3-C-C-CH2- 006 Ci-CH2-CH2-CH2-CH3-CH2-CH3-(CH2) 3-C-C-CH2- 007 CH3- (CH3) 2CH- CH3- (CH2) 3-C=-C-CH2- 008 CH3-CH2- (CH3) 2CH-CH3-(CH2) 3-C-C-CH2- 009 (CH3) 2N- (CH3) 2CH-CH3-(CH2) 3-C-C-CH2- 010 CH3-CH2-CH2- (CH3) 2CH- CH3- (CH2) 3-C-C-CH2- 011 (CH3) 2CH- (CH3) 2CH- CH3- (CH2) 3-C-C-CH2- 012 Cl-CH2-CH2-CH2- (CH3) 2CH- CH3- (CH2) 3-C=C-CH2- 013 CH3-CH3-CH2-CH2-CH3-(CH2) 3-C-C-CH2- 014 CH3-CH2-CH3-CH2-CH2-CH3-(CH2) 3-C-C-CH2- 015 (CH3) 2N- CH3-CH2-CH2-CH3- (CH2) 3-C=C-CH2- 016 CH3-CH2-CH2-CH3-CH2-CH2-CH3- (CH2) 3-C-C-CH2- 017 (CH3) 2CH-CH3-CH2-CH2-CH3-(CH2) 3-C-C-CH2- 018 Cl-CH2-CH2-CH2-CH3-CH2-CH2-CH3-(CH2) 3-C=C-CH2- 019 CH3-CCH (CH2) 3-C=C-CH2- 020 CH3-CH2-CCH-CH3- (CH2) 3-C---C-CH2- 021 (CH3) 2N-CCH CH3-(CH2) 3-C-C-CH2- 022 CH3-CH2-CH2-CCH-CH3- (CH2) 3-C-C-CH2- 023 (CH3) 2CH-CCH CH3-(CH2) 3-C-C-CH2- 024 Cl-CH2-CH2-CH2-CCH-CH3- (CH2) 3-C-C-CH2- 025 CH3-CH2=CH-CH2-CH3-(CH2) 3-C-C-CH2- 026 CH3-CH2-CH2=CH-CH2-CH3- (CH2) 3-C-C-CH2- 027 (CH3) 2N-CH2=CH-CH2-CH3-(CH2) 3-C-C-CH2- 028 CH3-CH2-CH2-CH2=CH-CH2-CH3- (CH2) 3-C=C-CH2- 029 (CH3) 2CH- CH2=CH-CH2-CH3- (CH2) 3-C-=C-CH2- 030 Cl-CH2-CH2-CH2-CH2=CH-CH2-CH3-(CH2) 3-C-C-CH2- 031 CH3-CH=-C-CH2-CH3- (CH2) 3-C=C-CH2- 032 CH3-CH2-CH-C-CH2-CH3-(CH2) 3-C-C-CH2- 033 (CH3) 2N-CH=C-CH2-CH3- (CH2) 3-C=C-CH2- 034 CH3-CH2-CH2-CH-C-CH2-CH3-(CH2) 3-C-C-CH2- 035 (CH3) 2CH- CH=C-CH2-CH3- (CH2) 3-C-C-CH2- 036 Cl-CH2-CH2-CH2-CH-C-CH2-CH3-(CH2) 3-C-C-CH2- 037 CH3-CH3-CH2-CH (CH3)-CH3-(CH2) 3-C-C-CH2- 038 CH3-CH2-CH3-CH2-CH (CH3)-CH3-(CH2) 3-C-C-CH2- 039 (CH3) 2N- CH3-CH2-CH (CH3)- CH3- (CH2) 3-C=C-CH2- 040 CH3-CH2-CH2-CH3-CH2-CH (CH3)-CH3-(CH2) 3-C-C-CH2- 041 (CH3) 2CH- CH3-CH2-CH (CH3)- CH3- (CH2) 3-C=C-CH2- 042 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)- CH3- (CH2) 3-C=C-CH2- 045 CH3-CH3-CH2-CH2- 046 CH3-CH2-CH3-CH2-D=CH2_ L-CH- 047 (CH3) 2N- CH3-CH2-CH2- 048 CH3-CH2-CHz-CH3-CH2--H2- 049 (CH3) 2CH-CH3-CH2-D=CH2_ 050 Cl-CH2-CH2-CH2-CH3-CH2-H2- 51 CH3- (CH3) 2CH-D+CH2 052 CH3-CH2- (CH3) 2CH- >-= CH2- 053 (CH3) 2N- (CH3) 2CH- 054 CH3-CH2-CH2- (CH3) 2CH-D=CH2_ 055 (CH3) 2CH- (CH3) 2CH-D+CH2 056 Cl-CH2-CH2-CH2- (CH3) 2CH-D+CH2 057 CH3-CH3-CH2-CH2-CH2- 058 CH3-CH2-CH3-CH2-CH2-CH2- 059 (CH3) 2N-CH3-CH2-CH2-D+CH2 060 CH3-CH2-CH2-CH3-CH2-CH2-CH 2- 061 (CH3) 2CH- CH3-CH2-CH2- D=CH2- 062 Cl-CH2-CH2-CH2-CH3-CH2-CH2-D=CH2_ I/ 063 CH3-CCH D=CH2_ 064 CH3-CH2-CCH-D=CH2- 065 (CH3) 2N- CCH-D= 066 CH3-CH2-CH2-CCH-=CH2- 067 (CH3) 2CH- CCH-=CH2- 068 CI-CH2-CH2-CH2-CCH--CH2- 069 CH3-CH2=CH-CH2-CH2- 070 J" 071 (CH3) 2N-CH2=CH-CH2-D=CH2_ 072 CH3-CH2-CH2-CH2=CH-CH2- v 073 (CH3) 2CH-CH2=CH-CH2-D=CH2_ 074 Cl-CH2-CH2-CH2-CH2=CH-CHz- D--=CH2- 075 CH3-CH-C-CH2-D=CH2_ 076 CH3-CH2-CH C-CH2-FCH2- V 077 (CH3) 2N-CH-C-CH2-D=CH2_ - 078 CH3-CH2-CH2-CH-_-C-CH2- (CH2- - 079 (CH3) 2CH- CH=-C-CH2-CH2- 080 Cl-CH2-CH2-CH2-CH-C-CH2-D=CH2 «-- 081 CH3-CH3-CH2-CH (CH3)->=CH2- I/ 082 CH3-CH2-CH3-CH2-CH (CH3)- = v 083 (CH3) 2N- CH3-CH2-CH (CH3)- D=C H2- 084 CH3-CH2-CH2-CH3-CH2-CH (CH3)- D-= CH2- 085 (CH3) 2CH- CH3-CH2-CH (CH3)- D-=C H2- 088 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)-D+C I/ 087 CH3-CH3-CH2-Ph-C-C-CH 088 CH3-CH2-CH3-CH2-Ph-C-C-CH2- 089 (CH3) 2N-CH3-CH2-Ph-C-C-CH 090 CH3-CH2-CH2-CH3-CH2-Ph-C-C-CH 091 (CH3) 2CH-CH3-CH2-Ph-C=C-CH2- 092 Cl-CH2-CH2-CH2-CH3-CH2-Ph-C-C-CH2- 093 CH3- (CH3) 2CH- Ph-C=-C-CH2- 094 CH3-CH2- (CH3) 2CH- Ph-C=-C-CH2- 095 (CH3) 2N- (CH3) j2CH-Ph-C-C-CH2- 096 CH3-CH2-CH2- (CH3) 2CH- Ph-C=-C-CH2- 097 (CH3) 2CH- (CH3) 2CH-Ph-C=C-CH2- 098 Cl-CH2-CH2-CH2- (CH3) 2CH- Ph-C=C-CH2- 099 CH3-CH3-CH2-CH2-Ph-C-C-CH2- 100 CH3-CH2-CH3-CH2-CH2-Ph-C=C-CH2- 101 (CH3) 2N-CH3-CH2-CH2-Ph-C-C-CH2- 102 CH3-CH2-CH2-CH3-CH2-CH2-Ph-C-C-CH2- 103 (CH3) 2CH-CH3-CH2-CH2-Ph-C-C-CH2- 104 CI-CH2-CH2-CH2-CH3-CH2-CH2-Ph-C-C-CH2- 105 CH3-CCH Ph-C-C-CH2- 106 CH3-CH2-CCH-Ph-C--_C-CH2- 107 (CH3) 2N-CCH Ph-C-C-CH2- 108 CH3-CH2-CH2-CCH-Ph-C---C-CH2- 109 (CH3) 2CH-CCH Ph-C-C-CH2- 110 Cl-CH2-CH2-CH2-CCH-Ph-C-C-CH2- 111 CH3-CH2=CH-CH2-Ph-C-C-CH2- 112 CH3-CH2-CH2=CH-CH2-Ph-C-C-CH 113 (CH3) 2N-CH2=CH-CH2-Ph-C-C-CH2- 114 CH3-CH2-CH2-CH2=CH-CH2-Ph-C-C-CH2- 115 (CH3) 2CH- CH2=CH-CH2-Ph-C=-C-CH2- 116 Cl-CH2-CH2-CH2-CH2=CH-CH2-Ph-C-C-CH2- 117 CH3-CH-C-CH2-Ph-C-C-CH2- 118 CH3-CH2-CH-C-CH2-Ph-C=C-CH2- 119 (CH3) 2N-CH--C-CH2-Ph-C-C-CH 120 CH3-CH2-CH2-CH-C-CH2-Ph-C-C-CH2- 121 (CH3) 2CH-CH-C-CH2-Ph-C-C-CH 122 Cl-CH2-CH2-CH2-CH--C-CH2-Ph-C-C-CH 123 CH3-CH3-CH2-CH (CH3)- Ph-C=-C-CH2- 124 CH3-CH2-CH3-CH2-CH (CH3)- Ph-C=-C-CH2- 125 (CH3) 2N-CH3-CH2-CH (CH3)-Ph-C-C-CH 126 CH3-CH2-CH2-CH3-CH2-CH (CH3)- Ph-C=-C-CH2- 127 (CH3) 2CH-CH3-CH2-CH (CH3)-Ph-C-C-CH2- 128 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)-Ph-C-C-CH2- 129 CH3-CH3-CH2- (4-F-Ph)-C_C-CH2- 130 CH3-CH2-CH3-CH2- (4-F-Ph)-C-C-CH2- 131 (CH3) 2N-CH3-CH2- (4-F-Ph)-C_C-CH2- 132 CH3-CH2-CH2-CH3-CH2- (4-F-Ph)-C-C-CH2- 133 (CH3) 2CH- CH3-CH2- (4-F-Ph)-C=C-CH2- 134 Cl-CH2-CH2-CH2-CH3-CH2- (4-F-Ph)-C-=C-CH2- 135 CH3- (CH3) 2CH- (4-F-Ph)-C-C-CH2- 136 CH3-CH2- (CH3) 2CH- (4-F-Ph)-C_C-CH2- 137 (CH3) 2N- (CH3) 2CH- (4-F-Ph)-C-C-CH2- 138 CH3-CH2-CH2- (CH3) 2CH- (4-F-Ph)-C_C-CH2- 139 (CH3) 2CH- (CH3) 2CH- (4-F-Ph)-C_C-CH2- 140 CI-CH2-CH2-CH2- (CH3) 2CH- (4-F-Ph)-C_C-CH2- 141 CH3-CH3-CH2-CH2- (4-F-Ph)-C_C-CH2- 142 CH3-CH2-CH3-CH2-CH2- (4-F-Ph)-C-C-CH2- 143 (CH3) 2N-CH3-CH2-CH2- (4-F-Ph)-C=C-CH2- 144 CH3-CH2-CH2-CH3-CH2-CH2- (4-F-Ph)-C=-C-CH2- 145 (CH3) 2CH-CH3-CH2-CH2- (4-F-Ph)-C_C-CH2- 146 Cl-CH2-CH2-CH2-CH3-CH2-CH2- (4-F-Ph)-C_C-CH2- 147 CH3-CCH (4-F-Ph)-C_C-CH2- 148 CH3-CH2-CCH (4-F-Ph)-C_C-CH2- 149 (CH3) 2N-CCH (4-F-Ph)-C-C-CH2- 150 CH3-CH2-CH2-rCH- (4-F-Ph)-C--C-CH2- 151 (CH3) 2CH-CCH (4-F-Ph)-C_C-CH2- 152 Cl-CH2-CH2-CH2-CCH- (4-F-Ph)-C--_C-CH2- 153 CH3-CH2=CH-CH2- (4-F-Ph)-C=-C-CH2- 154 CH3-CH2-CH2=CH-CH2- (4-F-Ph)-C=C-CH2- 155 (CH3) 2N- CH2=CH-CH2- (4-F-Ph)-C=-C-CH2- 156 CH3-CH2-CH2-CH2=CH-CH2- (4-F-Ph)-C-C-CH2 157 (CH3) 2CH- CH2=CH-CH2- (4-F-Ph)-C=C-CH2- 158 Cl-CH2-CH2-CH2-CH2=CH-CH2- (4-F-Ph)-C_C-CH2- 159 CH3-CH=-C-CH2- (4-F-Ph)-C=-C-CH2- 160 CH3-CH2-CH-C-CH2- (4-F-Ph)-C_C-CH2- 161 (CH3) 2N-CH=C-CH2- (4-F-Ph)-C=C-CH2- 162 CH3-CH2-CH2-CH--C-CH2- (4-F-Ph)-C_C-CH2- 163 (CH3) 2CH- CH-=C-CH2- (4-F-Ph)-C=-C-CH2- 164 CI-CH2-CH2-CH2-CH-C-CH2- (4-F-Ph)-C=-C-CH2- 165 CH3-CH3-CH2-CH (CH3)- (4-F-Ph)-C=-C-CH2- 166 CH3-CH2-CH3-CH2-CH (CH3)- (4-F-Ph)-C=C-CH2- 167 (CH3) 2N-CH3-CH2-CH (CH3)- (4-F-Ph)-C-C-CH2- 168 CH3-CH2-CH2-CH3-CH2-CH (CH3)- (4-F-Ph)-C--C-CH2- 169 (CH3) 2CH- CH3-CH2-CH (CH3)- (4-F-Ph)-C--C-CH2- 170 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)- (4-F-Ph)-C_C-CH2- 171 CH3-CH3-CH2- (4-CI-Ph)-C-C-CH2- 172 CH3-CH2-CH3-CH2- (4-CI-Ph)-C-C-CH2- 173 (CH3) 2N-CH3-CH2- (4-CI-Ph)-C-C-CH2- 174 CH3-CH2-CH2-CH3-CH2- (4-CI-Ph)-C-C-CH2- 175 (CH3) 2CH-CH3-CH2- (4-CI-Ph)-C-C-CH2- 176 Cl-CH2-CH2-CH2-CH3-CH2- (4-CI-Ph)-C=C-CH2- 177 CH3- (CH3) 2CH- (4-CI-Ph)-C_C-CH2- 178 CH3-CH2- (CH3) 2CH- (4-CI-Ph)-C_C-CH2- 179 (CH3) 2N- (CH3) 2CH- (4-CI-Ph)-C-C-CH2- 180 CH3-CH2-CH2- (CH3) 2CH- (4-CI-Ph)-C-C-CH2- 181 (CH3) 2CH- (CH3) 2CH- (4-CI-Ph)-C-C-CH2- 182 CI-CH2-CH2-CH2- (CH3) 2CH- (4-CI-Ph)-C-C-CH2- 183 CH3-CH3-CH2-CH2- (4-CI-Ph)-C--C-CH2- 184 CH3-CH2-CH3-CH2-CH2- (4-CI-Ph)-C=C-CH2- 185 (CH3) 2N- CH3-CH2-CH2- (4-CI-Ph)-C=C-CH2- 186 CH3-CH2-CH2-CH3-CH2-CH2- (4-Cf-Ph)-C--C-CH2- 187 (CH3) 2CH-CH3-CH2-CH2- (4-CI-Ph)-C-C-CH2- 188 Cl-CH2-CH2-CH2-CH3-CH2-CH2- (4-CI-Ph)-C-C-CH2- 189 CH3-CCH (4-CI-Ph)-C_C-CH2- 190 CH3-CH2-DCH- (4-Cl-Ph)-C=-C-CH2- 191 (CH3) 2N-CCH (4-CI-Ph)-C-C-CH2- 192 CH3-CH2-CH2-CCH (4-CI-Ph)-C-C-CH2- 193 (CH3) 2CH- CCH (4-CI-Ph)-C-C-CH2- 194 Cl-CH2-CH2-CH2-SCH- (4-CI-Ph)-C-C-CH2- 195 CH3-CH2=CH-CH2- (4-CI-Ph)-C-C-CH2- 196 CH3-CH2-CH2=CH-CH2- (4-CI-Ph)-C-C-CH2- 197 (CH3) 2N- CH2=CH-CH2- (4-ClPh)-C#C-CH2- 198 CH3-CH2-CH2- CH2-CH-CH2- (4-Cl-Ph)-C#C-CH2- 199 (CH3) 2CH- CH2=CH-CH2- (4-CI-Ph)-C=C-CH2- 200 Cl-CH2-CH2-CH2- CH2-CH-CH2- (4-Cl-Ph)-C#C-CH2- 201 CH3- CH#C-CH2- (4-Cl-Ph)-C#C-CH2- 202 CH3-CH2-CH-C-CH2- (4-CI-Ph)-C-C-CH2- 203 (CH3) 2N- CH#C-CH2- (4-Cl-Ph)-C#C-CH2- 204 CH3-CH2-CH2-CH-C-CH2- (4-CI-Ph)-C-C-CH2- 205 (CH3) 2CH- CH#C-CH2- (4-Cl-Ph)-C#C-CH2- 206 Cl-CH2-CH2-CH2-CH-C-CH2- (4-CI-Ph)-C-C-CH2- 207 CH3-CH3-CH2-CH (CH3)- (4-CI-Ph)-C-C-CH2- 208 CH3-CH2-CH3-CH2-CH (CH3)- (4-Cl-Ph)-C#C-CH2- 209 (CH3) 2N- CH3-CH2-CH (CH3)- (4-CI-Ph)-C=C-CH2- 210 CH3-CH2-CH2-CH3-CH2-CH (CH3)- (4-CI-Ph)-C_C-CH2- 211 (CH3) 2CH- CH3-CH2-CH (CH3)- (4-CI-Ph)-C_C-CH2- 212 Cl-CH2-CH2-CH2- CH3-CH2-CH (CH3)- (4-Cl-Ph)-C#C-CH2- 213 CH3-CH3-CH2- (4-Br-Ph)-C--C-CH2- 214 CH3-CH2-CH3-CH2- (4-Br-Ph)-C--C-CH2- 215 (CH3) 2N- CH3-CH2- (4-Br-Ph)-C=-C-CH2- 216 CH3-CH2-CH2-CH3-CH2- (4-Br-Ph)-C=-C-CH2- 217 (CH3) 2CH- CH3-CH2- (4-Br-Ph)-C#C-CH2- 218 Cl-CH2-CH2-CH2- CH3-CH2- (4-Br-Ph)-C#C-CH2- 219 CH3- (CH3) 2CH- (4-Br-Ph)-C#C-CH2- 220 CH3-CH2- (CH3) 2CH- (4-Br-Ph)-C=-C-CH2- 221 (CH3) 2N- (CH3)2CH- (4-Br-Ph)-C#C-CH2- 222 CH3-CH2-CH2- (CH3) 2CH- (4-Br-Ph)-C=-C-CH2- 223 (CH3) 2CH- (CH3) 2CH- (4-Br-Ph)-C#C-CH2- 224 Cl-CH2-CH2-CH2- (CH3) 2CH- (4-Br-Ph)-C=C-CH2- 225 CH3-CH3-CH2-CH2- (4-Br-Ph)-C-C-CH2- 226 CH3-CH2-CH3-CH2-CH2- (4-Br-Ph)-C=-C-CH2- 227 (CH3) 2N-CH3-CH2-CH2- (4-Br-Ph)-C-C-CH2- 228 CH3-CH2-CH2-CH3-CH2-CH2- (4-Br-Ph)-C-C-CH2- 229 (CH3) 2CH- CH3-CH2-CH2- (4-Br-Ph)-C=-C-CH2- 230 CI-CH2-CH2-CH2-CH3-CH2-CH2- (4-Br-Ph)-C-C-CH2- 231 CH3-CCH (4-Br-Ph)-C-C-CH2- 232 CH3-CH2-CCH (4-Br-Ph)-C--C-CH2- 233 (CH3) 2N-CCH (4-Br-Ph)-C-C-CH2- 234 CH3-CH2-CH2-CCH (4-Br-Ph)-C-C-CH2 235 (CH3) 2CH-CCH (4-Br-Ph)-C--C-CH2- 236 Cl-CH2-CH2-CH2-CCH (4-Br-Ph)-C-C-CH2- 237 CH3-CH2=CH-CH2- (4-Br-Ph)-C-C-CH2- 238 CH3-CH2-CH2=CH-CH2- (4-Br-Ph)-C=-C-CH2- 239 (CH3) 2N-CH2=CH-CH2- (4-Br-Ph)-C=C-CH2- 240 CH3-CH2-CH2-CH2=CH-CH2- (4-Br-Ph)-C_C-CH2- 241 (CH3) 2CH- CH2=CH-CH2- (4-Br-Ph)-C=-C-CH2- 242 Cl-CH2-CH2-CH2-CH2=CH-CH2- (4-Br-Ph)-C-C-CH2- 243 CH3-CH=-C-CH2- (4-Br-Ph)-C--C-CH2- 244 CH3-CH2-CH=-C-CH2- (4-Br-Ph)-C=-C-CH2- 245 (CH3) 2N-CH_C-CH2- (4-Br-Ph)-C-C-CH2- 246 CH3-CH2-CH2-CH-C-CH2- (4-Br-Ph)-C-C-CH2- 247 (CH3) 2CH- CH=-C-CH2- (4-Br-Ph)-C=-C-CH2- 248 Cl-CH2-CH2-CH2-CH--C-CH2- (4-Br-Ph)-C=-C-CH2- 249 CH3-CH3-CH2-CH (CH3)- (4-Br-Ph)-C=-C-CH2- 250 CH3-CH2-CH3-CH2-CH (CH3)- (4-Br-Ph)-C-C-CH2- 251 (CH3) 2N- CH3-CH2-CH (CH3)- (4-Br-Ph)-C=C-CH2- 252 CH3-CH2-CH2-CH3-CH2-CH (CH3)- (4-Br-Ph)-C=-C-CH2- 253 (CH3) 2CH-CH3-CH2-CH (CH3)- (4-Br-Ph)-C_C-CH2- 254 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)- (4-Br-Ph)-C-C-CH2- 255 CH3-CH3-CH2-H 256 CH3-CH2-CH3-CH2-H 257 (CH3) 2N-CH3-CH2-H 258 CH3-CH2-CH2-CH3-CH2-H 259 (CH3) 2CH- CH3-CH2-H 260 Cl-CH2-CH2-CH2-CH3-CH2-H 261 CH3- (CH3) 2CH- H 262 CH3-CH2- (CH3) 2CH- H 263 (CH3) 2N- (CH3) 2CH- H 264 CH3-CH2-CH2- (CH3) 2CH- H 265 (CH3) 2CH- (CH3) 2CH- H 266 CI-CH2-CH2-CH2- (CH3) 2CH- H 267 CH3-CH3-CH2-CH2-H 268 CH3-CH2-CH3-CH2-CH2-H 269 (CH3) 2N- CH3-CH2-CH2-H 270 CH3-CH2-CH2-CH3-CH2-CH2-H 271 (CH3) 2CH- CH3-CH2-CH2-H 272 Cl-CH2-CH2-CH2-CH3-CH2-CH2-H 273 CH3-CCH H 274 CH3-CH2-CCH- 275 (CH3) 2N- CCH- 276 CH3-CH2-CH2-CCH- 277 (CH3) 2CH-CCH H 278 Cl-CH2-CH2-CH2-CCH- 279 CH3-CH2=CH-CH2-H 280 CH3-CH2-CH2=CH-CH2-H 281 (CH3) 2N- CH2=CH-CH2-H 282 CH3-CH2-CH2-CH2=CH-CH2-H 283 (CH3) 2CH- CH2=CH-CH2-H 284 Cl-CH2-CH2-CH2-CH2=CH-CH2-H 285 CH3-CH-C-CH2- 86 CH3-CH2-CH-C-CH2- 287 (CH3) 2N- CH--C-CH2-H 288 CH3-CH2-CH2-CH-C-CH2-H 289 (CH3) 2CH- CH=-C-CH2-H 290 Cl-CH2-CH2-CH2-CH-C-CH2-H 291 CH3-CH3-CH2-CH (CH3)- H 292 CH3-CH2-CH3-CH2-CH (CH3)-H 293 (CH3) 2N- CH3-CH2-CH (CH3)- H 294 CH3-CH2-CH2-CH3-CH2-CH (CH3)-H 295 (CH3) 2CH- CH3-CH2-CH (CH3)- H 296 CI-CH2-CH2-CH2-CH3-CH2-CH (CH3)-H 297 CH3-CH3-CH2-Ph-CH2- 298 CH3-CH2-CH3-CH2-Ph-CH2- 299 (CH3) 2N-CH3-CH2-Ph-CH2- 300 CH3-CH2-CH2-CH3-CH2-Ph-CH2- 301 (CH3) 2CH- CH3-CH2-Ph-CH2- 302 Cl-CH2-CH2-CH2-CH3-CH2-Ph-CH2- 3) 2CH- Ph-CH2- 304 CH3-CH2- (CH3) 2CH-Ph-CH2- 305 (CH3) 2N- (CH3) 2CH- Ph-CH2- 306 CH3-CH2-CH2- (CH3) 2CH-Ph-CH2- 307 (CH3) 2CH- (CH3) 2CH-Ph-CH2- 308 Cl-CH2-CH2-CH2- (CH3) 2CH-Ph-CH2- 309 CH3-CH3-CH2-CH2-Ph-CH2- 310 CH3-CH2-CH3-CH2-CH2-Ph-CH2- 311 (CH3) 2N- CH3-CH2-CH2-Ph-CH2- 312 CH3-CH2-CH2-CH3-CH2-CH2-Ph-CH2- 313 (CH3) 2CH-CH3-CH2-CH2-Ph-CH2- 314 Cl-CH2-CH2-CH2-CH3-CH2-CH2-Ph-CH2- 315 CH3-CCH Ph-CH2- 316 CH3-CH2-CCH Ph-CH2- 317 (CH3) 2N-CCH-Ph-CH2- 318 CH3-CH2-CH2-CCH Ph-CH2- 319 (CH3) 2CH- CCH-Ph-CH2- 320 Cl-CH2-CH2-CH2-CCH Ph-CH2- 321 CH3-CH2=CH-CH2-Ph-CH2- 322 CH3-CH2-CH2=CH-CH2-Ph-CH2- 323 (CH3) 2N-CH2=CH-CH2-Ph-CH2- 324 CH3-CH2-CH2-CH2=CH-CH2-Ph-CH2- 325 (CH3) 2CH-CH2=CH-CH2-Ph-CH2- 326 Cl-CH2-CH2-CH2-CH2=CH-CH2-Ph-CH2- 327 CH3-CH=-C-CH2-Ph-CH2- 328 CH3-CH2-CH-C-CH2-Ph-CH2- 329 (CH3) 2N-CH-C-CH2-Ph-CH2- 330 CH3-CH2-CH2-CH=-C-CH2-Ph-CH2- 331 (CH3) 2CH-CH--C-CH2-Ph-CH2- 332 Cl-CH2-CH2-CH2-CH-C-CH2-Ph-CH2- 333 CH3-CH3-CH2-CH (CH3)- Ph-CH2- 334 CH3-CH2-CH3-CH2-CH (CH3)- Ph-CH2- 335 (CH3) 2N-CH3-CH2-CH (CH3)-Ph-CH2- 336 CH3-CH2-CH2-CH3-CH2-CH (CH3)-Ph-CH2- 337 (CH3) 2CH-CH3-CH2-CH (CH3)-Ph-CH2- 338 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)-Ph-CH2- 339 CH3-CH3-CH2- (4-CI-Ph)-CH2- 340 CH3-CH2-CH3-CH2- (4-CI-Ph)-CH2- 341 (CH3) 2N-CH3-CH2- (4-CI-Ph)-CH2- 342 CH3-CH2-CH2-CH3-CH2- (4-CI-Ph)-CH2- 343 (CH3) 2CH-CH3-CH2- (4-CI-Ph)-CH2- 344 Cl-CH2-CH2-CH2-CH3-CH2- (4-CI-Ph)-CH2- 345 CH3- (CH3) 2CH- (4-CI-Ph)-CH2- 346 CH3-CH2- (CH3) 2CH- (4-CI-Ph)-CH2- 347 (CH3) 2N- (CH3) 2CH- (4-CI-Ph)-CH2- 348 CH3-CH2-CH2- (CH3) 2CH- (4-CI-Ph)-CH2- 349 (CH3) 2CH- (CH3) 2CH- (4-CI-Ph)-CH2- 350 Cl-CH2-CH2-CH2- (CH3) 2CH- (4-CI-Ph)-CH2- 351 CH3-CH3-CH2-CH2- (4-CI-Ph)-CH2- 352 CH3-CH2-CH3-CH2-CH2- (4-CI-Ph)-CH2- 353 (CH3) 2N-CH3-CH2-CH2- (4-CI-Ph)-CH2- 354 CH3-CH2-CH2-CH3-CH2-CH2- (4-CI-Ph)-CH2- 355 (CH3) 2CH-CH3-CH2-CH2- (4-CI-Ph)-CH2- 356 Cl-CH2-CH2-CH2-CH3-CH2-CH2- (4-CI-Ph)-CH2- 357 CH3-CCH (4-CI-Ph)-CH2- 358 CH3-CH2-CCH (4-CI-Ph)-CH2- 359 (CH3) 2N-CCH (4-CI-Ph)-CH2- 360 CH3-CH2-CH2-CCH (4-CI-Ph)-CH2- 361 (CH3) 2CH-CCH (4-CI-Ph)-CH2- 362 Cl-CH2-CH2-CHz- (4-CI-Ph)-CH2- CCH- 363 CH3-CH2=CH-CH2- (4-CI-Ph)-CH2- 364 CH3-CH2-CH2=CH-CH2- (4-CI-Ph)-CH2- 365 (CH3) 2N-CH2=CH-CH2- (4-CI-Ph)-CH2- 366 CH3-CH2-CH2-CH2=CH-CH2- (4-CI-Ph)-CH2- 367 (CH3) 2CH-CH2=CH-CH2- (4-CI-Ph)-CH2- 368 Cl-CH2-CH2-CH2-CH2=CH-CH2- (4-CI-Ph)-CH2- 369 CH3-CH-C-CH2- (4-CI-Ph)-CH2- 370 CH3-CH2-CH-C-CH2- (4-CI-Ph)-CH2- 371 (CH3) 2N-CH-C-CH2- (4-CI-Ph)-CH2- 372 CH3-CH2-CH2-CH--C-CH2- (4-Cl-Ph)-CH2- 373 (CH3) 2CH-CH C-CH2- (4-CI-Ph)-CH2- 374 Cl-CH2-CH2-CH2-CH-C-CH2- (4-CI-Ph)-CH2- 375 CH3-CH3-CH2-CH (CH3)- (4-CI-Ph)-CH2- 376 CH3-CH2-CH3-CH2-CH (CH3)- (4-CI-Ph)-CH2- 378 (CH3) 2N-CH3-CH2-CH (CH3)- (4-CI-Ph)-CH2- 379 CH3-CH2-CH2-CH3-CH2-CH (CH3)- (4-CI-Ph)-CH2- 380 (CH3) 2CH-CH3-CH2-CH (CH3)- (4-CI-Ph)-CH2- 381 2-CH2-CH2-3-CH2-CH (CH3)--CH2- 382 CH3-CH3-CH2- (3-CI-Ph)-CH2- 383 CH3-CH2-CH3-CH2- (3-CI-Ph)-CH2- 384 (CH3) 2N-CH3-CH2- (3-CI-Ph)-CH2- 385 CH3-CH2-CH2-CH3-CH2- (3-CI-Ph)-CH2- 386 (CH3) 2CH-CH3-CH2- (3-CI-Ph)-CH2- 387 Cl-CH2-CH2-CH2-CH3-CH2- (3-CI-Ph)-CH2- 388 CH3- (CH3) 2CH- (3-CI-Ph)-CH2- 389 CH3-CH2- (CH3) 2CH- (3-CI-Ph)-CH2- 390 (CH3) 2N- (CH3) 2CH- (3-CI-Ph)-CH2- 391 CH3-CH2-CH2- (CH3) 2CH- (3-CI-Ph)-CH2- 392 (CH3) 2CH- (CH3) 2CH- (3-CI-Ph)-CH2- 393 Cl-CH2-CH2-CH2- (CH3) 2CH- (3-CI-Ph)-CH2- 394 CH3-CH3-CH2-CH2- (3-CI-Ph)-CH2- 395 CH3-CH2-CH3-CH2-CH2- (3-CI-Ph)-CH2- 396 (CH3) 2N-CH3-CH2-CH2- (3-CI-Ph)-CH2- 397 CH3-CH2-CH2-CH3-CH2-CH2- (3-CI-Ph)-CH2- 398 (CH3) 2CH-CH3-CH2-CH2- (3-CI-Ph)-CH2- 399 Cl-CH2-CH2-CH2-CH3-CH2-CH2- (3-CI-Ph)-CH2- 400 CH3-CCH (3-CI-Ph)-CH2- 401 CH3-CH2-CCH (3-CI-Ph)-CH2- 402 (CH3) 2N-CCH (3-CI-Ph)-CH2- 403 CH3-CH2-CH2-CCH- (3-CI-Ph)-CH2- 404 (CH3) 2CH-CCH (3-CI-Ph5-CH2- 405 CI-CH2-CH2-CH2-CCH (3-CI-Ph)-CH2- 406 CH3-CH2=CH-CH2- (3-CI-Ph)-CH2- 407 CH3-CH2-CH2=CH-CH2- (3-CI-Ph)-CH2- 408 (CH3) 2N-CH2=CH-CH2- (3-CI-Ph)-CH2- 409 CH3-CH2-CH2-CH2=CH-CH2- (3-CI-Ph)-CH2- 410 (CH3) 2CH- CH2=CH-CH2- (3-CI-Ph)-CH2- 411 Cl-CH2-CH2-CH2-CH2=CH-CH2- (3-CI-Ph)-CH2- 412 CH3-CH-C-CH2- (3-CI-Ph) 413 CH3-CH2-CH=C-CH2- (3-CI-Ph)-CH2- 414 (CH3) 2N-CH-C-CH2- (3-CI-Ph)-CH2- 415 CH3-CH2-CH2-CH-C-CH2- (3-CI-Ph)-CH2 416 (CH3) 2CH-CH-C-CH2- (3-CI-Ph)-CH2- 417 CI-CH2-CH2-CH2-CH-C-CH2- (3-CI-Ph)-CH2- 418 CH3-CH3-CH2-CH (CH3)- (3-CI-Ph)-CH2- 419 CH3-CH2-CH3-CH2-CH (CH3)- (3-CI-Ph)-CH2 420 (CH3) 2N-CH3-CH2-CH (CH3)- (3-CI-Ph)-CH2- 421 CH3-CH2-CH2-CH3-CH2-CH (CH3)- (3-CI-Ph)-CH2- 422 (CH3) 2CH-CH3-CH2-CH (CH3)- (3-CI-Ph)-CH2- 423 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)- (3-CI-Ph)-CH2- 424 CH3-CH3-CH2- (3-CF3-Ph)-CH2- 425 CH3-CH2-CH3-CH2- (3-CF3-Ph)-CH2- 426 (CH3) 2N-CH3-CH2- (3-CF3-Ph)-CH2- 427 CH3-CH2-CH2-CH3-CH2- (3-CF3-Ph)-CH2- 428 (CH3) 2CH-CH3-CH2- (3-CF3-Ph)-CH2- 429 Cl-CH2-CH2-CH2-CH3-CH2- (3-CF3-Ph)-CH2 430 CH3- (CH3) 2CH- (3-CF3-Ph)-CH2- 431 CH3-CH2- (CH3) 2CH- (3-CF3-Ph)-CH2- 432 (CH3) 2N- (CH3) 2CH- (3-CF3-Ph)-CH2- 433 CH3-CH2-CH2- (CH3) 2CH- (3-CF3-Ph)-CH2- 434 (CH3) 2CH- (CH3) 2CH- (3-CF3-Ph)-CH2- 435 Cl-CH2-CH2-CH2- (CH3) 2CH- (3-CF3-Ph)-CH2- 436 CH3-CH3-CH2-CH2- (3-CF3-Ph)-CH2- 437 CH3-CH2-CH3-CH2-CH2- (3-CF3-Ph)-CH2- 438 (CH3) 2N-CH3-CH2-CH2- (3-CF3-Ph)-CH2- 439 CH3-CH2-CH2-CH3-CH2-CH2- (3-CF3-Ph)-CH2- 440 (CH3) 2CH- CH3-CH2-CH2- (3-CF3-Ph)-CH2- 441 Cl-CH2-CH2-CH2-CH3-CH2-CH2- (3-CF3-Ph)-CH2- 442 CH3-CCH (3-CF3-Ph)-CH2- 443 CH3-CH2-CCH- (3-CF3-Ph)-CH2- 444 (CH3) 2N-CCH (3-CF3-Ph)-CH2- 445 CH3-CH2-CH2-CCH- (3-CF3-Ph)-CH2- 446 (CH3) 2CH-CCH (3-CF3-Ph)-CH2- 447 Cl-CH2-CH2-CH2-CCH (3-CF3-Ph)-CH2- 448 CH3-CH2=CH-CH2- (3-CF3-Ph)-CH2- 449 CH3-CH2-CH2=CH-CH2- (3-CF3-Ph)-CH2- 450 (CH3) 2N-CH2=CH-CH2- (3-CF3-Ph)-CH2- 451 CH3-CH2-CH2-CH2=CH-CH2- (3-CF3-Ph)-CH2- 452 (CH3) 2CH-CH2=CH-CH2- (3-CF3-Ph)-CH2- 453 Cl-CH2-CH2-CH2-CH2=CH-CH2- (3-CF3-Ph)-CH2- 454 CH3-CH-C-CH2- (3-CF3-Ph)-CH2- 455 CH3-CH2-CH=-C-CH2- (3-CF3-Ph)-CH2- 456 (CH3) 2N- CH=C-CH2- (3-CF3-Ph)-CH2- 457 CH3-CH2-CH2-CH-C-CH2- (3-CF3-Ph)-CH2- 458 (CH3) 2CH-CH-C-CH2- (3-CF3-Ph)-CH2- 459 Cl-CH2-CH2-CH2-CH=-C-CH2- (3-CF3-Ph)-CH2- 460 CH3-CH3-CH2-CH (CH3)- (3-CF3-Ph)-CH2- 461 CH3-CH2-CH3-CH2-CH (CH3)- (3-CF3-Ph)-CH2- 462 (CH3) 2N-CH3-CH2-CH (CH3)- (3-CF3-Ph)-CH2- 463 CH3-CH2-CH2-CH3-CH2-CH (CH3)- (3-CF3-Ph)-CH2- 464 (CH3) 2CH- CH3-CH2-CH (CH3)- (3-CF3-Ph)-CH2- 465 Cl-CH2-CH2-CH2-CH3-CH2-CH (CH3)- (3-CF3-Ph)-CH2- Table 12 : Compounds represented by the Formula 1. 12 where the combination of the groups R, and R3 corresponds to each row in table B.

Table 13 : Compounds represented by the Formula 1. 13 where the combination of the groups R, and R3 corresponds to each row in table B.

Table 14 : Compounds represented by the Formula 1. 14 where the combination of the groups R, and R3 corresponds to each row in table B.

Table B No. R, R3 001 (CH3-CH2) 2N-CH3-CH2- 002 CH3-CH2- (CH3) N- CH3-CH2- 003 CH3-CH2- CON- 004 CH3- (CH2) 2-CH2- CH3-CH2- 005 (CH3) 2CH-CH2- CH3-CH2- 006 CH3-CH2- (CH3) CH- CH3-CH2- 007 (CH3) 3C- CH3-CH2- 008 CH2=CH-CH3-CH2- 009 CH3-CH2- CCH- 010 (CH3-CH2) 2N- (CH3) 2CH- 011 CH3-CH2- (CH3) N- (CH3) 2CH- 012 (CH3) 2CH- CON- 013 CH3- (CH2) 2-CH2- (CH3) 2CH- 014 (CH3) 2CH-CH2- (CH3) 2CH- 015 CH3-CH2- (CH3) CH- (CH3) 2CH- 016 (CH3) 3C- (CH3) 2CH- 017 CH2=CH- (CH3) zCH- 018/5 (CH3) 2CH- \nCH- u 019 (CH3-CH2) 2N- CH3-CH2-CH2 020 CH3-CH2- (CH3) N- CH3-CH2-CH2 021 CH3-CH2-CH2 CON- 022 CH3- (CH2) 2-CH2- CH3-CH2-CH2 023 (CH3) 2CH-CH2-CH3-CH2-CH2 024 CH3-CH2- (CH3) CH- CH3-CH2-CH2 025 (CH3) 3C-CH3-CH2-CH2 026 CH2=CH-CH3-CH2-CH2 027 CH3-CH2-CH2 CCH- 028 (CH3-CH2) 2N- CH3-CH2- (CH3) CH- 029 CH3-CH2- (CH3) N- CH3-CH2- (CH3) CH- 030 CH3-CH2- (CH3) CH- OU- 031 CH3- (CH2) 2-CH2- CH3-CH2- (CH3) CH- 032 (CH3) 2CH-CH2- CH3-CH2- (CH3) CH- 033 CH3-CH2- (CH3) CH- CH3-CH2- (CH3) CH- 034 (CH3) 3C- CH3-CH2- (CH3) CH- 035 CH2=CH-CH3-CH2- (CH3) CH- 036 CH3-CH2- (CH3) CH- \XCH- 037 (CH3-CH2) 2N-CCH 038 CH3-CH2-(CH3) N-CCH 039 CN-CCH N 040 CH3-(CH2) 2-CH2-CCH 041 (CH3) 2CH-CH2-CCH 042 CH3-CH2-(CH3) CH-CCH 043 (CH3) 3C-CCH 044 CH2=CH-CCH- 045 CCH- CCH- 046 CH3-HO-CH2- 047 CH3-CH2-HO-CH2- 048 (CH3) 2N- HO-CH2- 049 CH3-CH2-CH2-HO-CH2- 050 (CH3) 2CH- HO-CH2- 051 CH3-CH2- (CH3) CH- HO-CH2- 052 CH3-HO- (CH3) CH- 053 CH3-CH2-HO- (CH3) CH- 054 (CH3) 2N- HO- (CH3) CH- 055 CH3-CH2-CH2-HO- (CH3) CH- 056 (CH3) 2CH- HO- (CH3) CH- 057 CH3-CH2-(CH3)CH- HO-(CH3) CH- 058 CH3- (CH3) 3C-O- (CH3) CH- 059 CH3-CH2- (CH3) 3C-O- (CH3) CH- 060 (CH3) 2N- (CH3) 3C-O- (CH3) CH- 061 CH3-CH2-CH2- (CH3) 3C-O- (CH3) CH- 062 (CH3) 2CH- (CH3) 3C-O- (CH3) CH- 063 CH3-CH2- (CH3) CH- (CH3)3C-O-(CH3)CH- 064 CH3-CH3-S-CH2-CH2- 065 CH3-CH2-CH3-S-CH2-CH2- 066 (CH3) 2N- CH3-S-CH2-CH2- 067 CH3-CH2-CH2-CH3-S-CH2-CH2- 068 (CH3) 2CH- CH3-S-CH2-CH2- 069 CH3-CH2-(CH3)CH- CH3-S-CH2-CH2- 070 CH3-HS-CH2-CH2- 071 CH3-CH2- HS-CH2-CH2- 072 (CH3) 2N-HS-CH2-CH2- 073 CH3-CH2-CH2- HS-CH2-CH2- 074 (CH3) 2CH- HS-CH2-CH2- 075 CH3-CH2- (CH3) CH- HS-CH2-CH2- 076 CH3- (CH3) 3C- 077 CH3-CH2- (CH3) 3C- 078 (CH3) 2N- (CH3) 3C- 079 CH3-CH2-CH2- (CH3) 3C- 080 (CH3) 2CH- (CH3) 3C- 081 CH3-CH2-(CH2) CH- (CH3) 3C- Table 15 : Compounds represented by the Formula 1. 15 where the combination of the group Rio corresponds to each row in table C. Table 16 : Compounds represented by the Formula 1. 16 where the combination of the group Rio corresponds to each row in table C.

Table C No. Rio 001 CH3-CH2-C (CH3) H-C-C-CH2- 002 (CH3) 3C-C-C-CH 003 (CH3) 2CH-CH2-C-C-CH2- 004 CH3- (CH2) 4-C=C-CH2- 005 -cl2- 006 -CH- 007 (4-CH3-Ph)-C--C-CH 008 (2-Cl-Ph)-C--_C-CH2- 009 (3-CI-Ph)-C_C-CH2- 010 (3-Br-Ph)-C-=C-CH2- 011 (3-F-Ph)-C-C-CH2- 012 (3-CH3-Ph)-C=C-CH2- 013 (2, 4-d !-C !-Ph)-C=C-CH2- 014 (3, 4-di-Ct-Ph)-C=C-CH2- 015 (3, 4-di-F-Ph)-C=-C-CH2- 016 (3-CH3-4-CI-Ph)-C-C-CH2- 017 (3-CH3-4-Br-Ph)-C=-C-CH2- 018 (3-CF3-Ph)-C=-C-CH2- 019 (4-CF30-Ph)-C=-C-CH2- 020 (4-Et-Ph)-C=-C-CH2- 021 [4- (CH3) 3C-Ph]-C=C-CH2- 022 (4-CH2=CH-Ph)-C=-C-CH2- 023 (4-CH_C-Ph)-C-C-CH2- 024 (4-CH3-CO-Ph)-C=-C-CH2- 025 (4-CH300C-Ph)-C=C-CH2- 026 (4-CH30-Ph)-C=C-CH2- 027 =r5, 027 CH2- 028 cl2- s 029 N5<CH2- 030 N 030 (+CH2- N 031 Ph- (CH3) CH- 032 Ph- (CH3) 2C- 033 (3-F-Ph)-CH2- 034 (4-Br-Ph)-CH2- 035 (4-J-Ph)-CH2- 036 (4-CH3-Ph)-CH2- 037 (4-CH30-Ph)-CH2- 038 (4-CF30-Ph)-CH2- 039 (4-F-Ph)-CH2- 040 (2, 4-di-F-Ph)-CH2- 041 (3, 4-di-F-Ph)-CH2- 042 (3, 4-di-Br-Ph)-CH2- 043 (3, 4-di-C)-Ph)-CH2- 044 (3-CI-4-CH3-Ph)-CH2- 045 (3-CH3-4-CI-Ph)-CH2- 046 (2, 4, 5-tri-CI-Ph)-CH2- 047 CH2- 049 A s 2 049 cl2- 050 CI4CH2- CI S CH2- 051 Br S CH2- 052bru Br S CH2- 053 CH2- N 054 N N- czech F3 C-N 2- =N 056 N CH2- 057 Ph-CH=CH-CH2- 058 (4-CI-Ph)-CH=CH-CH2- 059 (4-F-Ph)-CH=CH-CH2- 060 (4-Br-Ph)-CH=CH-CH2- 061 (3-CF3-Ph)-CH=CH-2- 062 Ph-CH2-CH2- 063 Ph-(CH2) 2-CH2- 064 (4-Cl-Ph)- (CH2) 2-CH2- 065 (4-Br-Ph)- (CH2) 2-CH2- 066 Ph-O-CH2-CH2- 067 (4-CI-Ph)-O-CH2-CH2- 068 (4-F-Ph)-O-CH2-CH2- 069 (4-Br-Ph)-O-CH2-CH2- 070 (3-F-Ph)-O-CH2-CH2- 071 (3, 4-di-CI-Ph)-O-CH2-CH2- 072 (4-CI-Ph)-O-(CH3) CH-CH2- 073 (3, 4-di-CI-Ph)-O-(CH3) CH-CH2- 074 Ph-N (CH3)-CH2-CH2- 075 Ph-N (CH2-CH3)-CH2-CH2- 076 Ph-S-CH2-CH2- 077 (4-CI-Ph)-S-CH2-CH2- Formulations may be prepared analogously to those described in, for example, WO 95/30651.

Biological Examples D-1 : Action against Plasmopara viticola (downy mildew) on vines 5 week old grape seedlings cv. Gutedel are treated with the formulated test compound in a spray chamber. One day after application grape plants are inoculated by spraying a sporangia suspension (4 x 104 sporangia/ml) on the lower leaf side of the test plants. After an incubation period of 6 days at +21 °C and 95% r. h. in a greenhouse the disease incidence is assessed.

Compounds of Tables 1 to 16 exhibit a good fungicidal action against Plasmopara viticola on vines. Compounds A1. 3 and A1. 4 at 200 ppm inhibit fungal infestation in this test to a least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

D-2 : Action against Phytophthora (late blight) on tomato plants 3 week old tomato plants cv. Roter Gnom are treated with the formulated test compound in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (2 x 104 sporangia/ml) on the test plants. After an incubation period of 4 days at +18 C and 95% r. h. in a growth chamber the disease incidence is assessed.

Compounds of Tables 1 to 16 exhibit a long-lasting effect against fungus infestation.

Compounds A1. 3 and A1. 4 at 200 ppm inhibit fungal infestation in this test to a least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

D-3 : Action against Phytophthora (late blight) on potato plants 5 week old potato plants cv. Bintje are treated with the formulated test compound in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (14 x 104 sporangia/ml) on the test plants. After an incubation period of 4 days at +18°C and 95% r. h. in a growth chamber the disease incidence is assessed.

Fungal infestation is effectively controlled with compounds of Tables 1 to 16.